Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aldermed is a healthcare services and medical technology company that specializes in providing point-of-care superficial radiotherapy (SRT) for the treatment of non-melanoma skin cancer. The company operates a unique mobile service model, known as the SRTeam, which brings low-dose radiation therapy equipment and specialized clinical staff directly to dermatology and cosmetic surgery offices. In addition to its radiotherapy services, Aldermed acts as a pharmaceutical packager and labeler for a variety of over-the-counter (OTC) dermatological products, including hydrocortisone creams and zinc oxide ointments. By integrating medical device distribution with clinical support and pharmaceutical packaging, Aldermed enables healthcare providers to offer non-surgical treatment options for skin cancer and common skin conditions. The company's business model is designed to improve patient outcomes and practice efficiency in the dermatology sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aldermed.